EURICAN® L4
About EURICAN® L4
EURICAN® L4 is the latest generation of dog vaccines against leptospirosis:
Active immunisation of dogs from seven weeks of age to prevent or reduce mortality, clinical signs, infection, bacterial excretion, renal carriage and renal lesions caused by four serogroups: L. Canicola, L. Icterohaemorrhagiae, L. Grippotyphosa, L. Australis.
EURICAN® L4 benefits:
- unique efficacy demonstrated through six indications
- protection of clinical signs and mortality for four serogroups1
- quick onset of immunity as early as two weeks after primary vaccination
- adjuvant-free
1 Indications for EURICAN® L4 as per summary of product characteristics (SPC): prevention or reduction of mortality, clinical signs, infection, urinary excretion, renal carriage, and renal lesions caused by L. Canicola, L. Icterohaemorrhagiae, L. Grippotyphosa, and L. Australis. For L. Canicola, L. Icterohaemorrhagiae, L. Grippotyphosa prevention of mortality and clinical signs was not demonstrated at the duration of immunity timepoint.
Product Key Facts
Indications
Canine vaccine against leptospirosis
Brand name
EURICAN® L4
Active ingredients
Leptospira interrogans serogroup and serovar Canicola
Leptospira interrogans serogroup and serovar Icterohaemorrhagiae
Leptospira interrogans serogroup and serovar Grippotyphosa
Leptospira interrogans serogroup Australis and serovar Bratislava